Sloan Kattering’s Widening Institutional Reckoning Over Ethics Crisis Snags Center’s Top Executive

Memorial Sloan Kettering Cancer Center President, Dr. Craig Thompson, announced that he will resign from the boards of Merck and Charles River Laboratories. Merck is the maker of the blockbuster cancer treatment Keytruda. Memorial Sloan Kettering Cancer Center has been thrust under the microscope recently over controversy involving top officials' financial conflicts of interest.

from Kaiser Health News https://ift.tt/2y9Z43a